A meta-analysis of cortical inhibition and excitability using transcranial magnetic stimulation in psychiatric disorders

Clinical Neurophysiology

Volumn 124, Issue 7, 2013, Pages 1309-1320

  Radhu, Natasha ^a   de Jesus, Danilo R ^a   Ravindran, Lakshmi N ^a   Zanjani, Anosha ^a   Fitzgerald, Paul B ^b   Daskalakis, Zafiris J ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Cortical excitation; Cortical inhibition; Motor cortex; Neurophysiology; Psychiatric disorders; Transcranial magnetic stimulation

Indexed keywords

ARTICLE; BRAIN CORTEX INHIBITION; CORTICAL SILENT PERIOD; EVOKED MUSCLE RESPONSE; EXCITABILITY; HUMAN; INTRACORTICAL FACILITATION; MAJOR DEPRESSION; NERVOUS SYSTEM FUNCTION; NERVOUS SYSTEM PARAMETERS; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; RESTING MOTOR THRESHOLD; SCHIZOPHRENIA; SHORT INTERVAL CORTICAL INHIBITION; TRANSCRANIAL MAGNETIC STIMULATION;

DATABASES, FACTUAL; DEPRESSIVE DISORDER, MAJOR; EVOKED POTENTIALS, MOTOR; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MOTOR CORTEX; NEURAL INHIBITION; OBSESSIVE-COMPULSIVE DISORDER; REACTION TIME; SCHIZOPHRENIA; TIME FACTORS; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84878920526     PISSN: 13882457     EISSN: 18728952     Source Type: Journal    
DOI: 10.1016/j.clinph.2013.01.014     Document Type: Article

References (81)

1. Abarbanel J.M., Lemberg T., Yaroslavski U., Grisaru N., Belmaker R.H. Electrophysiological responses to transcranial magnetic stimulation in depression and schizophrenia. Biol Psychiatry 1996, 40:148-150.
2. Arnold P.D., Sicard T., Burroughs E., Richter M.A., Kennedy J.L. Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Arch Gen Psychiatry 2006, 63:769-776.
3. Bajbouj M., Gallinat J., Niehaus L., Lang U.E., Roricht S., Meyer B.U. Abnormalities of inhibitory neuronal mechanisms in the motor cortex of patients with schizophrenia. Pharmacopsychiatry 2004, 37:74-80.
4. Bajbouj M., Lisanby S.H., Lang U.E., Danker-Hopfe H., Heuser I., Neu P. Evidence for impaired cortical inhibition in patients with unipolar major depression. Biol Psychiatry 2006, 59:395-400.
5. Barker A.T., Jalinous R., Freeston I.L. Non-invasive magnetic stimulation of human motor cortex. Lancet 1985, 1:1106-1107.
6. Benes F.M., Berretta S. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 2001, 25:1-27.
7. Boroojerdi B., Topper R., Foltys H., Meincke U. Transcallosal inhibition and motor conduction studies in patients with schizophrenia using transcranial magnetic stimulation. Br J Psychiatry 1999, 175:375-379.
8. Cantello R., Gianelli M., Civardi C., Mutani R. Magnetic brain stimulation: the silent period after the motor evoked potential. Neurology 1992, 42:1951-1959.
9. Chipchase L., Schabrun S., Cohen L., Hodges P., Ridding M., Rothwell J., et al. A checklist for assessing the methodological quality of studies using transcranial magnetic stimulation to study the motor system: an international consensus study. Clin Neurophysiol 2012, 123:1698-1704.
10. Chroni E., Lekka N.P., Tsoussis I., Nikolakopoulou A., Paschalis C., Beratis S. Effect of exercise on motor evoked potentials elicited by transcranial magnetic stimulation in psychiatric patients. J Clin Neurophysiol 2002, 19:240-244.
11. Daskalakis Z.J., Christensen B.K., Chen R., Fitzgerald P.B., Zipursky R.B., Kapur S. Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation. Arch Gen Psychiatry 2002, 59:347-354.
12. Daskalakis Z.J., Christensen B.K., Fitzgerald P.B., Moller B., Fountain S.I., Chen R. Increased cortical inhibition in persons with schizophrenia treated with clozapine. J Psychopharmacol 2008, 22:203-209.
13. Daskalakis Z.J., Farzan F., Barr M.S., Maller J.J., Chen R., Fitzgerald P.B. Long-interval cortical inhibition from the dorsolateral prefrontal cortex: a TMS-EEG study. Neuropsychopharmacology 2008, 33:2860-2869.
14. Daskalakis Z.J., Fitzgerald P.B., Christensen B.K. The role of cortical inhibition in the pathophysiology and treatment of schizophrenia. Brain Res Rev 2007, 56:427-442.
15. DeFelipe J., Conley M., Jones E.G. Long-range focal collateralization of axons arising from corticocortical cells in monkey sensory-motor cortex. J Neurosci 1986, 6:3749-3766.
16. Dickel D.E., Veenstra-VanderWeele J., Cox N.J., Wu X., Fischer D.J., Van Etten-Lee M., et al. Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder. Arch Gen Psychiatry 2006, 63:778-785.
17. Eichhammer P., Wiegand R., Kharraz A., Langguth B., Binder H., Hajak G. Cortical excitability in neuroleptic-naive first-episode schizophrenic patients. Schizophr Res 2004, 67:253-259.
18. Enticott P.G., Hoy K.E., Herring S.E., Johnston P.J., Daskalakis Z.J., Fitzgerald P.B. Reduced motor facilitation during action observation in schizophrenia: a mirror neuron deficit?. Schizophr Res 2008, 102:116-121.
19. Farzan F., Barr M.S., Levinson A.J., Chen R., Wong W., Fitzgerald P.B., et al. Evidence for gamma inhibition deficits in the dorsolateral prefrontal cortex of patients with schizophrenia. Brain 2010, 133:1505-1514.
20. Farzan F., Barr M.S., Levinson A.J., Chen R., Wong W., Fitzgerald P.B., et al. Reliability of long-interval cortical inhibition in healthy human subjects: a TMS-EEG study. J Neurophysiol 2010, 104:1339-1346.
21. Fitzgerald P.B., Brown T.L., Daskalakis Z.J., DeCastella A., Kulkarni J. A study of transcallosal inhibition in schizophrenia using transcranial magnetic stimulation. Schizophr Res 2002, 56:199-209.
22. Fitzgerald P.B., Brown T.L., Daskalakis Z.J., Kulkarni J. A transcranial magnetic stimulation study of inhibitory deficits in the motor cortex in patients with schizophrenia. Psychiatry Res 2002, 114:11-22.
23. Fitzgerald P.B., Brown T.L., Daskalakis Z.J., Kulkarni J. A transcranial magnetic stimulation study of the effects of olanzapine and risperidone on motor cortical excitability in patients with schizophrenia. Psychopharmacology (Berl) 2002, 162:74-81.
24. Fitzgerald P.B., Brown T.L., Marston N.A., Daskalakis Z.J., de Castella A., Bradshaw J.L., et al. Motor cortical excitability and clinical response to rTMS in depression. J Affect Disord 2004, 82:71-76.
25. Fitzgerald P.B., Brown T.L., Marston N.A., Oxley T., De Castella A., Daskalakis Z.J., et al. Reduced plastic brain responses in schizophrenia: a transcranial magnetic stimulation study. Schizophr Res 2004, 71:17-26.
26. Fitzgerald P.B., Brown T.L., Marston N.A., Oxley T.J., de Castella A., Daskalakis Z.J., et al. A transcranial magnetic stimulation study of abnormal cortical inhibition in schizophrenia. Psychiatry Res 2003, 118:197-207.
27. Fitzgerald P.B., Daskalakis Z.J., Hoy K., Farzan F., Upton D.J., Cooper N.R., et al. Cortical inhibition in motor and non-motor regions: a combined TMS-EEG study. Clin EEG Neurosci 2008, 39:112-117.
28. Gilbert C.D., Wiesel T.N. Receptive field dynamics in adult primary visual cortex. Nature 1992, 356:150-152.
29. Greenberg B.D., Ziemann U., Cora-Locatelli G., Harmon A., Murphy D.L., Keel J.C., et al. Altered cortical excitability in obsessive-compulsive disorder. Neurology 2000, 54:142-147.
30. Greenberg B.D., Ziemann U., Harmon A., Murphy D.L., Wassermann E.M. Decreased neuronal inhibition in cerebral cortex in obsessive-compulsive disorder on transcranial magnetic stimulation. Lancet 1998, 352:881-882.
31. Grunhaus L., Polak D., Amiaz R., Dannon P.N. Motor-evoked potential amplitudes elicited by transcranial magnetic stimulation do not differentiate between patients and normal controls. Int J Neuropsychopharmacol 2003, 6:371-378.
32. Hasan A., Wobrock T., Grefkes C., Labusga M., Levold K., Schneider-Axmann T., et al. Deficient inhibitory cortical networks in antipsychotic-naive subjects at risk of developing first-episode psychosis and first-episode schizophrenia patients: a cross-sectional study. Biol Psychiatry 2012, 72:744-751.
33. Herbsman T., Forster L., Molnar C., Dougherty R., Christie D., Koola J., et al. Motor threshold in transcranial magnetic stimulation: the impact of white matter fiber orientation and skull-to-cortex distance. Hum Brain Mapp 2009, 30:2044-2055.
34. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
35. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
36. Hoy K.E., Georgiou-Karistianis N., Laycock R., Fitzgerald P.B. Using transcranial magnetic stimulation to investigate the cortical origins of motor overflow: a study in schizophrenia and healthy controls. Psychol Med 2007, 37:583-594.
37. Jones E.G. GABAergic neurons and their role in cortical plasticity in primates. Cereb Cortex 1993, 3:361-372.
38. Krnjevic K. Role of GABA in cerebral cortex. Can J Physiol Pharmacol 1997, 75:439-451.
39. Kujirai T., Caramia M.D., Rothwell J.C., Day B.L., Thompson P.D., Ferbert A., et al. Corticocortical inhibition in human motor cortex. J Physiol 1993, 471:501-519.
40. Langguth B., Eichhammer P., Spranz C., Landgrebe M., Frick U., Sand P., et al. Modulation of human motor cortex excitability by quetiapine. Psychopharmacology (Berl) 2008, 196:623-629.
41. Lefaucheur J.P., Lucas B., Andraud F., Hogrel J.Y., Bellivier F., Del Cul A., et al. Inter-hemispheric asymmetry of motor corticospinal excitability in major depression studied by transcranial magnetic stimulation. J Psychiatr Res 2008, 42:389-398.
42. Levinson A.J., Fitzgerald P.B., Favalli G., Blumberger D.M., Daigle M., Daskalakis Z.J. Evidence of cortical inhibitory deficits in major depressive disorder. Biol Psychiatry 2010, 67:458-464.
43. Levinson A.J., Young L.T., Fitzgerald P.B., Daskalakis Z.J. Cortical inhibitory dysfunction in bipolar disorder: a study using transcranial magnetic stimulation. J Clin Psychopharmacol 2007, 27:493-497.
44. Lewis D.A., Pierri J.N., Volk D.W., Melchitzky D.S., Woo T.U. Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia. Biol Psychiatry 1999, 46:616-626.
45. Liu S.K., Fitzgerald P.B., Daigle M., Chen R., Daskalakis Z.J. The relationship between cortical inhibition, antipsychotic treatment, and the symptoms of schizophrenia. Biol Psychiatry 2009, 65:503-509.
46. Maeda F., Keenan J.P., Pascual-Leone A. Interhemispheric asymmetry of motor cortical excitability in major depression as measured by transcranial magnetic stimulation. Br J Psychiatry 2000, 177:169-173.
47. Manganotti P., Bortolomasi M., Zanette G., Pawelzik T., Giacopuzzi M., Fiaschi A. Intravenous clomipramine decreases excitability of human motor cortex. A study with paired magnetic stimulation. J Neurol Sci 2001, 184:27-32.
48. McCormick D.A. GABA as an inhibitory neurotransmitter in human cerebral cortex. J Neurophysiol 1989, 62:1018-1027.
49. McDonnell M.N., Orekhov Y., Ziemann U. The role of GABA(B) receptors in intracortical inhibition in the human motor cortex. Exp Brain Res 2006, 173:86-93.
50. Minelli A., Bortolomasi M., Scassellati C., Salvoro B., Avesani M., Manganotti P. Effects of intravenous antidepressant drugs on the excitability of human motor cortex: a study with paired magnetic stimulation on depressed patients. Brain Stimul 2010, 3:15-21.
51. Nakamura H., Kitagawa H., Kawaguchi Y., Tsuji H. Intracortical facilitation and inhibition after transcranial magnetic stimulation in conscious humans. J Physiol 1997, 498(Pt 3):817-823.
52. Oxley T., Fitzgerald P.B., Brown T.L., de Castella A., Daskalakis Z.J., Kulkarni J. Repetitive transcranial magnetic stimulation reveals abnormal plastic response to premotor cortex stimulation in schizophrenia. Biol Psychiatry 2004, 56:628-633.
53. Pascual-Leone A., Manoach D.S., Birnbaum R., Goff D.C. Motor cortical excitability in schizophrenia. Biol Psychiatry 2002, 52:24-31.
54. Paulus W., Classen J., Cohen L.G., Large C.H., Di Lazzaro V., Nitsche M., et al. State of the art: pharmacologic effects on cortical excitability measures tested by transcranial magnetic stimulation. Brain Stimulation 2008, 1:151-163.
55. Reid P.D., Daniels B., Rybak M., Turnier-Shea Y., Pridmore S. Cortical excitability of psychiatric disorders: reduced post-exercise facilitation in depression compared to schizophrenia and controls. Aust N Z J Psychiatry 2002, 36:669-673.
56. Richter M.A., de Jesus D.R., Hoppenbrouwers S., Daigle M., Deluce J., Ravindran L.N., et al. Evidence for cortical inhibitory and excitatory dysfunction in obsessive compulsive disorder. Neuropsychopharmacology 2012, 37:1144-1151.
57. Robol E., Fiaschi A., Manganotti P. Effects of citalopram on the excitability of the human motor cortex: a paired magnetic stimulation study. J Neurol Sci 2004, 221:41-46.
58. Rossini P.M., Barker A.T., Berardelli A., Caramia M.D., Caruso G., Cracco R.Q., et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol 1994, 91:79-92.
59. Samuels J., Wang Y., Riddle M.A., Greenberg B.D., Fyer A.J., McCracken J.T., et al. Comprehensive family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet 2011, 156B:472-477.
60. Sanacora G., Saricicek A. GABAergic contributions to the pathophysiology of depression and the mechanism of antidepressant action. CNS Neurol Disord Drug Targets 2007, 6:127-140.
61. Sanger T.D., Garg R.R., Chen R. Interactions between two different inhibitory systems in the human motor cortex. J Physiol 2001, 530:307-317.
62. Schieber M.H., Hibbard L.S. How somatotopic is the motor cortex hand area?. Science 1993, 261:489-492.
63. Shajahan P.M., Glabus M.F., Gooding P.A., Shah P.J., Ebmeier K.P. Reduced cortical excitability in depression. Impaired post-exercise motor facilitation with transcranial magnetic stimulation. Br J Psychiatry 1999, 174:449-454.
64. Siebner H.R., Dressnandt J., Auer C., Conrad B. Continuous intrathecal baclofen infusions induced a marked increase of the transcranially evoked silent period in a patient with generalized dystonia. Muscle Nerve 1998, 21:1209-1212.
65. Soubasi E., Chroni E., Gourzis P., Zisis A., Beratis S., Papathanasopoulos P. Cortical motor neurophysiology of patients with schizophrenia: a study using transcranial magnetic stimulation. Psychiatry Res 2010, 176:132-136.
66. Stan A.D., Lewis D.A. Altered cortical GABA neurotransmission in schizophrenia: insights into novel therapeutic strategies. Curr Pharm Biotechnol 2012, 13:1557-1562.
67. Steele J.D., Glabus M.F., Shajahan P.M., Ebmeier K.P. Increased cortical inhibition in depression: a prolonged silent period with transcranial magnetic stimulation (TMS). Psychol Med 2000, 30:565-570.
68. Stewart S.E., Platko J., Fagerness J., Birns J., Jenike E., Smoller J.W., et al. A genetic family-based association study of OLIG2 in obsessive-compulsive disorder. Arch Gen Psychiatry 2007, 64:209-214.
69. Valls-Sole J., Pascual-Leone A., Wassermann E.M., Hallett M. Human motor evoked responses to paired transcranial magnetic stimuli. Electroencephalogr Clin Neurophysiol 1992, 85:355-364.
70. Voyiaziakis E., Evgrafov O., Li D., Yoon H.J., Tabares P., Samuels J., et al. Association of SLC6A4 variants with obsessive-compulsive disorder in a large multicenter US family study. Mol Psychiatry 2011, 16:108-120.
71. Wang X.J., Buzsaki G. Gamma oscillation by synaptic inhibition in a hippocampal interneuronal network model. J Neurosci 1996, 16:6402-6413.
72. Werhahn K.J., Kunesch E., Noachtar S., Benecke R., Classen J. Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans. J Physiol (Lond) 1999, 517:591-597.
73. Wobrock T., Hasan A., Malchow B., Wolff-Menzler C., Guse B., Lang N., et al. Increased cortical inhibition deficits in first-episode schizophrenia with comorbid cannabis abuse. Psychopharmacology (Berl) 2010, 208:353-363.
74. Wobrock T., Schneider-Axmann T., Retz W., Rosler M., Kadovic D., Falkai P., et al. Motor circuit abnormalities in first-episode schizophrenia assessed with transcranial magnetic stimulation. Pharmacopsychiatry 2009, 42:194-201.
75. Wobrock T., Schneider M., Kadovic D., Schneider-Axmann T., Ecker U.K., Retz W., et al. Reduced cortical inhibition in first-episode schizophrenia. Schizophr Res 2008, 105:252-261.
76. Zaaroor M., Pratt H., Starr A. Time course of motor excitability before and after a task-related movement. Neurophysiol Clin 2003, 33:130-137.
77. Zai G., Arnold P., Burroughs E., Barr C.L., Richter M.A., Kennedy J.L. Evidence for the gamma-amino-butyric acid type B receptor 1 (GABBR1) gene as a susceptibility factor in obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet 2005, 134B:25-29.
78. Ziemann U., Chen R., Cohen L.G., Hallett M. Dextromethorphan decreases the excitability of the human motor cortex. Neurology 1998, 51:1320-1324.
79. Ziemann U., Lonnecker S., Steinhoff B.J., Paulus W. The effect of lorazepam on the motor cortical excitability in man. Exp Brain Res 1996, 109:127-135.
80. Ziemann U., Lonnecker S., Steinhoff B.J., Paulus W. Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol 1996, 40:367-378.
81. Ziemann U., Tergau F., Bruns D., Baudewig J., Paulus W. Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs. Electroencephalogr Clin Neurophysiol 1997, 105:430-437.